News

2014 WGND Annual Meeting, Barcelona, Oct. 29, 15h-19h

We invite you to join us for the Stop TB Partnership Working Group on New Drugs’ Annual Meeting 2014 at AC Hotel Barcelona Forum, Barcelona, Spain, on Wednesday, Oct. 29th from 15:00 to 19:00.
This meeting is held before the 45th Union World Conference on Lung Health (The Union). During the meeting we will review and discuss progress of projects in the Global TB Drug Pipeline and Drug Discovery Portfolio, the new Global Plan development, review WGND 2014 activities, and discuss other relevant topics. Representatives from pharmaceutical companies, research consortia and organizations, NGOs and academia will be participating.

An agenda will be posted in the next few weeks. Light refreshments will be served.

Registration is free.

If you have any questions or want to register, send an e-mail to wgnd@newtbdrugs.org

Explore. Learn. Join the Conversation at www.newtbdrugs.org.

More News
14 Aug 2019
FDA released the following press release on Wednesday, August 14th: The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis (TB) of the lungs. “The threat of...
27 Jun 2019
-- Globe Newswire reported on June 20th -- Spero Therapeutics, Inc. , a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant (MDR) bacterial infections and rare diseases, today...
5 Jun 2019
**Update: The US FDA Antimicrobial Drug Advisory Committee voted in favor of the NDA 14 to 4 on June 6th, 2019** The United States Food & Drug Administration (FDA) will host the Antimicrobial Drug Advisory Committee on Thursday, June 6th to discuss the new drug application (NDA) involving new...